# iNOPulse for COVID-19

> **NCT04398290** · PHASE2 · WITHDRAWN · sponsor: **Roger Alvarez**

## Conditions studied

- COVID-19
- Hypoxemia
- Hypoxemic Respiratory Failure

## Interventions

- **DRUG:** Inhaled nitric oxide (iNO)
- **DRUG:** Nitrogen gas
- **DRUG:** Oxygen gas

## Key facts

- **NCT ID:** NCT04398290
- **Lead sponsor:** Roger Alvarez
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-07-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** IRB AND FDA REVIEWS DEFERRED
- **Last updated:** 2020-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04398290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04398290, "iNOPulse for COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04398290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*